This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB04451/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04451/identifier/pubchem-compound/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04451/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04451/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04451
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04451 n10:DB04451
dcterms:title
4-Methylpiperazin-1-Yl Carbonyl Group
adms:identifier
n8:3269221 n9:46508298 n12:DB04451 n13:ODS
n3:IUPAC-Name
n4:271B5B16-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5B1C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5B1B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5B18-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5B19-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5B1A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5B14-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5B12-363D-11E5-9242-09173F13E4C5 n4:271B5B15-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5B13-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5B22-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5B23-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5B1D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5B1E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5B20-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5B1F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5B21-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5B27-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5B29-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5B2A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5B26-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5B25-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5B28-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5B17-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5B24-363D-11E5-9242-09173F13E4C5